Gender surprise for diabetes drugs

Overweight type 2 women on exenatide/metformin therapy lose much more weight and experience greater improvements across a number of parameters than men, say Chinese researchers.

Their study of 105 overweight or obese T2DM patients found that after six months of combination therapy women had lost an average of 8.2kg and men only 4.6kg.

Women had significantly improved insulin sensitivity and serum